News

Insights into Profound Medical's Upcoming Financial Results

Insights into Profound Medical's Upcoming Financial Results

Profound Medical Announces Financial Results Release Date

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN), a notable player in the medical device field, is gearing up to unveil its fourth quarter and full year results for 2024. The announcement will take place after market close on an upcoming Thursday. This presentation is highly anticipated as it showcases the company's performance and strategic direction.

Conference Call to Discuss Financial Results

The management team at Profound Medical will follow the earnings announcement with a conference call scheduled for 4:30 p.m. ET. They will walk through the financial results and share insights into key business developments during the reporting period. Such calls are essential for investors and stakeholders to understand the company's trajectory and growth potential.

About Profound Medical Corp.

Profound Medical is on the cutting edge of medical technology, focusing on customizable and incision-free treatments for diseased tissue. Their flagship technology, TULSA-PRO, integrates advanced real-time MRI capabilities with ultrasound technology. This combination allows for precision treatment of various prostate conditions, positioning TULSA-PRO as a potential standard in prostate disease treatment.

Innovative Treatments with TULSA-PRO

The TULSA-PRO system employs robotically-driven transurethral ultrasound combined with closed-loop temperature feedback to deliver effective results. This innovative procedure is distinguished by its ability to preserve urinary continence and sexual function, while effectively targeting and destroying diseased tissue through the application of focused ultrasound energy. Patients undergoing TULSA experience a quick recovery without the need for hospitalization, thanks to the non-invasive nature of the procedure.

Profound's Additional Therapeutic Platforms

In addition to TULSA-PRO, Profound Medical is also pioneering the Sonalleve system, which is designed to treat uterine fibroids and provide palliative care for bone metastases. This technology has received CE marking and various regulatory approvals, including from the FDA and China's medical administration. The company is actively pursuing further applications for Sonalleve in treating cancers and hyperthermia therapy, underscoring their dedication to expanding their therapeutic portfolio.

Commitment to Innovation in Healthcare

Profound Medical's commitment to innovation is evident in its strategic approach to expanding its therapeutic solutions. Through rigorous research and development, the company is exploring additional markets that could benefit from their unique technologies, continuing to improve patient outcomes in the field of medical treatment.

Contact Information

For more details or inquiries related to investor relations, Stephen Kilmer can be reached via email or telephone. Stephen is an essential point of contact for those looking to gain further insights into the company’s plans and financial health.

Stephen Kilmer
Investor Relations
skilmer@profoundmedical.com
T: 647.872.4849

Frequently Asked Questions

When will Profound Medical's financial results be announced?

Profound Medical will announce its financial results on an upcoming Thursday after the market closes.

What is TULSA-PRO used for?

TULSA-PRO is used for the ablation of prostate tissue, providing incision-free options for various prostate diseases.

How does Profound Medical ensure patient safety?

Profound Medical's technologies are designed with precision guidance, minimizing risks and ensuring quick recovery without hospitalization.

What additional markets is Profound exploring for Sonalleve?

Profound Medical is exploring non-invasive treatments for a variety of abdominal cancers and hyperthermia therapy with Sonalleve.

Who can I contact for investor relations at Profound Medical?

For investor relations inquiries, you can contact Stephen Kilmer via email at skilmer@profoundmedical.com or by phone at 647.872.4849.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 5

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 3

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 10

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 4

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 5

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 4

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 5

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 6

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 5

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading

Top 5 Most Recently Viewed Articles

Targa Resources Corp. Declares Quarter Dividend and Earnings Call

Updated Category News Views 221

Targa Resources Corp. Declares Quarterly Dividend Targa Resources Corp. has proudly announced its quarterly dividend for the fourth quarter of 2024, reinforcing its dedication to delivering shareholder value. The NYSE-listed company revealed that its board of directors has declared a cash dividend of $0.75 per common share, amounting to an impressive $3.00 per share on an...

Continue Reading
Denbright Dental Labs Welcomes David Casper as New CEO

Updated Category News Views 266

David Casper Takes Charge at Denbright Dental Labs Denbright Dental Labs has announced an important change in leadership with the appointment of David Casper as Chief Executive Officer. Known for its dedication to delivering top-quality dental prosthetics, the company aims to continue its success under Casper’s vast experience. An Experienced Leader in Dentistry David...

Continue Reading
Ascend Wellness Holdings Reveals New Share Buyback Initiative

Updated Category News Views 168

Ascend Wellness Holdings Introduces Share Buyback Initiative Ascend Wellness Holdings, Inc. (AAWH), a top-notch multi-state cannabis operator, has declared a new chapter in its commitment to shareholder value. The company's Board of Directors has authorized a share buyback program, which will commence soon, demonstrating Ascend's dedication to enhancing its financial...

Continue Reading
Expanding Access to Golf: TruGolf Links Teams Up with Local Developer

Updated Category News Views 330

TruGolf Links Teams Up for Expansion TruGolf Links Franchising, LLC, fully owned by TruGolf Holdings, Inc. (NASDAQ: TRUG), has embarked on an ambitious journey to enhance the golfing experience. With a pioneering spirit, the company has signed a regional development deal with John Young, whom they describe as not just an entrepreneur but a passionate advocate for building...

Continue Reading
Eramet's Q1 2025 Performance: Navigating Market Challenges

Updated Category News Views 367

Eramet's Stability Amid Market Fluctuations in Q1 2025 In the first quarter of 2025, Eramet reported an adjusted turnover of €742 million, reflecting stability compared to the same period in the previous year. This result, while steady, comes amidst various challenges that have affected operational efficiency and product sales. Key Financial Highlights The turnover...

Continue Reading